Cargando…

Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience

SIMPLE SUMMARY: The term mastocytosis denotes a heterogeneous group of rare disorders characterized by abnormal accumulation and activation of mast cells in various organs. Based on the WHO classification, mastocytosis can essentially be split into indolent and advanced systemic disease. Indolent ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ungerstedt, Johanna, Ljung, Christopher, Klimkowska, Monika, Gülen, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405903/ https://www.ncbi.nlm.nih.gov/pubmed/36010937 http://dx.doi.org/10.3390/cancers14163942

Ejemplares similares

Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis
por: Grootens, Jennine, et al.
Publicado: (2019)

Systemic Mastocytosis: Multidisciplinary Approach
por: Zanotti, Roberta, et al.
Publicado: (2021)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network
por: Zanotti, Roberta, et al.
Publicado: (2021)

Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients
por: Jarkvist, Jesper, et al.
Publicado: (2023)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary Approach
por: Zanelli, Magda, et al.
Publicado: (2021)

COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated
por: Lazarinis, Nikolaos, et al.
Publicado: (2022)

Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel
por: Velloso, Elvira D. Rodrigues Pereira, et al.
Publicado: (2022)

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019)

Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis
por: Lyberg, Katarina, et al.
Publicado: (2016)

Delayed Diagnosis of Adult Indolent Systemic Mastocytosis
por: Mikkelsen, Carsten Sauer, et al.
Publicado: (2014)

Mastocytosis in the skin in children and adults
por: Lange, Magdalena
Publicado: (2015)

Mastocytosis in children and adults: clinical disease heterogeneity
por: Lange, Magdalena, et al.
Publicado: (2012)

Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study
por: Bonadonna, Patrizia, et al.
Publicado: (2022)

An elusive case of systemic mastocytosis
por: Lee, JK, et al.
Publicado: (2010)

Precision Medicine in Systemic Mastocytosis
por: Nicolosi, Maura, et al.
Publicado: (2021)

Systemic Lymphadenopathic Mastocytosis with Eosinophilia
por: Im, Soyoung, et al.
Publicado: (2022)

Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston
por: Kanamori, Kelly Yoshimi, et al.
Publicado: (2015)

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
por: Iliakis, Theodoros, et al.
Publicado: (2014)

Mastocytosis and systemic sclerosis: a clinical association
por: Bagnato, Gianluca, et al.
Publicado: (2016)

Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Anesthetic experience in a pediatric patient with mastocytosis
por: Jo, Youn Yi, et al.
Publicado: (2011)

Systemic mastocytosis – a diagnostic challenge
por: Lladó, Ana Cristina Amorim Oliveira Gaia, et al.
Publicado: (2014)

Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019)

The Role of Avapritinib for the Treatment of Systemic Mastocytosis
por: Sumbly, Vikram, et al.
Publicado: (2021)

Systemic Mastocytosis: Radiological Point of View
por: Leone, Antonio, et al.
Publicado: (2021)

New Insights into the Pathogenesis of Systemic Mastocytosis
por: Li, Zhixiong
Publicado: (2021)

Treatment of Indolent and Advanced Systemic Mastocytosis
por: Buonomo, Alessandro, et al.
Publicado: (2022)

Target Therapies for Systemic Mastocytosis: An Update
por: Sciumè, Mariarita, et al.
Publicado: (2022)

Skin and bones: systemic mastocytosis and bone
por: Wang, Mawson, et al.
Publicado: (2023)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
por: Kluin-Nelemans, Hanneke C., et al.
Publicado: (2021)

Clinical and molecular categorization of progressive, adult-onset cutaneous mastocytosis
por: Tate, Courtney, et al.
Publicado: (2017)

Multidisciplinary Management of Pediatric Hepatoblastoma: A 20-Year Single-Center Experience
por: Tayfun Küpesiz, Funda, et al.
Publicado: (2022)

A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination
por: Sriskandarajah, Priya, et al.
Publicado: (2021)

Association of mastocytosis with interleukin 31 gene polymorphism
por: Nedoszytko, Boguslaw, et al.
Publicado: (2015)

Indolent systemic mastocytosis in a patient with ileocolitis
por: Chrysakopoulos, Georgios, et al.
Publicado: (2014)

Systemic Mastocytosis in Association with Small Lymphocytic Lymphoma
por: Iqbal, Muhammad F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_irvatcdj6j8e4c18i69bsggo7p